LP
DRTSW icon

LMR Partners’s Alpha Tau Medical Warrant DRTSW Stock Holding History

LMR Partners’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-112,986
Closed -$21.5K – 1307
2024
Q3 		$21.5K Buy
+112,986
New +$23.3K ﹤0.01% 1115

Other funds holding DRTSW

FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
VB
Value Base Tel Aviv, Israel $127M AUM 12.37% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LMR Partners's DRTSW Position: Q1 2026 in Review

LMR Partners increased its Alpha Tau Medical Warrant (DRTSW) stake by 263% in Q1 2026, buying an estimated $285K and bringing the position to 409,647 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

LMR Partners first reported a position in DRTSW in Q1 2022 and has held it in 16 quarters since. The position peaked at $660K in Q3 2022. 21 funds tracked by Wall St. Rank hold DRTSW as of Q1 2026.

  • LMR Partners held 409,647 shares of Alpha Tau Medical Warrant worth $410K as of Q1 2026.
  • LMR Partners bought 296,661 Alpha Tau Medical Warrant shares in Q1 2026, an estimated $285K.
  • Alpha Tau Medical Warrant made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1102 holding.
  • LMR Partners first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 16 quarters since.
  • LMR Partners's Alpha Tau Medical Warrant position peaked at $660K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.